state_legiscan_backfill · DC
Medical Cannabis Beverage Product Amendment Act of 2026
April 2, 2026
Summary
If enacted, this bill would create a medical cannabis beverage production endorsement allowing licensed medical cannabis manufacturers and certain alcohol manufacturers to produce infused beverages. The legislation also establishes tax requirements for medical cannabis products to ensure regulatory compliance for manufacturers and retailers.
AI-generated summary · May 20, 2026. Verify with your compliance counsel before acting.
How this was generated
We record the exact prompt, model, and output for every AI response so it can be audited for accuracy.
Source: https://lims.dccouncil.gov/Legislation/B26-0654
Common questions
- What does "Medical Cannabis Beverage Product Amendment Act of 2026" cover?
- If enacted, this bill would create a medical cannabis beverage production endorsement allowing licensed medical cannabis manufacturers and certain alcohol…
- When was it published?
- It was published on April 2, 2026.
Related updates
- Sigue Corporation Settlement Agreement and Consent Order issued by the Division of Banking
- Consent Order Sigue Corporation
- Ultralight FS,. Inc., formerly known as Obopay, Inc., also doing business as Obopay USA
- AMENDED Amerbank LLC/Dolare LLC
- Agreed Order
- Sigue Corporation Interim Consent Order issued by the Division of Banking